"Although DHS released a draft solicitation for BioWatch Gen-3 on Jan. 22, the department warned on Feb. 8 that it was merely collecting information from industry at this stage. DHS may move forward with acquiring new BioWatch technology after the department completes its analysis of alternatives (AoA) sometime late in 2013.
"The AoA will assess several possible alternative strategies based on technical feasibility, manageable risk and cost. Based on the results of the AoA, DHS will determine the most appropriate course of action," Walter said."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.